Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT04249219
Other study ID # H00022646
Secondary ID K99DA046563
Status Completed
Phase Early Phase 1
First received
Last updated
Start date August 4, 2021
Est. completion date August 15, 2022

Study information

Verified date September 2023
Source University of Massachusetts, Worcester
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

While conventional cigarette use continues to decline among youth and young adults, e-cigarette (EC) use is on the rise. The use of ECs during young adulthood, particularly 18 years of age, is especially alarming because it is not only a critical period in development but also a time when tobacco use is established. Additionally, the tobacco industry targets individuals of this age with the hope that they will one day progress to using combustible cigarettes. Advertising may be one of the reasons leading young people to use ECs, and the Food and Drug Administration (FDA) now has the authority to regulate EC advertisement features. The goal of the study is to determine which EC ad features most strongly influence young adults' attitudes, susceptibility, and intentions to use ECs. Fifteen ads from the most popular EC brands that employ a brand, product descriptions, and modeling features were selected. Young adults who are susceptible to EC use will come into the lab and view these ads. During exposure, they will be assessed for real-time visual attention using eye-tracking, orienting responses using heart rate, and arousal using skin conductance as well as pre- and post-ad self-report measures of attitudes, susceptibility, and behavioral intentions. These factors will help determine the most high impact features, which will be associated with the greatest visual attention, orienting responses, and arousal levels and changes in attitudes. Findings from this study will provide public health officials important and urgently needed information as to what advertising features are contributing to the sharp rise in the use of ECs among young adults.


Recruitment information / eligibility

Status Completed
Enrollment 62
Est. completion date August 15, 2022
Est. primary completion date August 15, 2022
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 26 Years
Eligibility Inclusion Criteria: - 18-26 years old, - Fluent in English, - Biochemically confirmed abstinence combusted tobacco or marijuana (eCO: exhaled carbon monoxide <6 parts per million) at time of visit - Reporting never trying an e-cigarette, not even a puff OR reporting having used an e-cigarette in the past but has not used in the past 30 days - Susceptibility to EC use, will be determined using the Susceptibility to Use Tobacco Products questionnaire Exclusion Criteria: - Younger than 18 years or older than 26 years - Not fluent in English - Not confirmed abstinent of combusted tobacco or marijuana - Use of an e-cigarette - Not susceptible to e-cigarette use

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Viewing e-cigarette ads
All participants will see the same e-cigarette ads presented in a random order.

Locations

Country Name City State
United States University of Massachusetts Medical School Worcester Massachusetts

Sponsors (2)

Lead Sponsor Collaborator
University of Massachusetts, Worcester National Institute on Drug Abuse (NIDA)

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary Attention to Specific ad Feature Heart rate was measured to assess the cognitive resources allocated to the message. Using three sensors applied to participants' fingers, electrocardiogram (ECG) signals were recorded with a Shimmer 3 EXG module, while viewing the advertisements and were sampled at 512 Hz. Heart change scores were computed using beats per minute (BPM) and subtracting the first second of the stimuli (participant had seen a black screen just prior) from scores for each second of message exposure for each participant. Then, scores were averaged across each advertisement. Lesser values indicated greater deceleration in heart rate, signaling more cognitive resources allocated to the message. Change from the first second of viewing to each subsequent second of the intervention (10 seconds per ad), averaged for each participant.
Primary Arousal Skin conductance or galvanic skin response was measured using three sensors applied to participants' fingers. Skin conductance measured if there was an emotional response and the intensity of the emotional response. A "peak" is a biological indicator that something happened, and the participant had an emotional response to it. The amplitude of each peak for each participant was measured and averaged per ad. The average amplitude of skin conductance peaks over the 10 second viewing window for each ad brand.
Primary Attention to Specific ad Feature Visual attention was assessed using an eye-tracker connected to the base of the computer screen. For each message, four areas of interest (AOI) were identified: 1) brand, 2) descriptor, 3) modeling, and 4) warning. All four AOIs were summed for a total number of milliseconds that a participant viewed the AOIs. Duration of seconds spent on all areas of interest during 10 second viewing window for each ad brand
Secondary Motivations to Avoid E-cigarettes Self-report Please rate on a scale from 0 (not at all) to 10 (very much). "How important is it to avoid e-cigarettes in the future?" "How confident are in avoiding e-cigarettes in the future?" "How ready are you to avoid e-cigarettes in the future?" "How committed are you to avoid e-cigarettes in the future?"
Scores were averaged for each ad for each participant. Then, an overall average was taken among all participants for each ad. Higher values indicate greater motivation to avoid e-cigarettes.
Immediately after viewing each ad
See also
  Status Clinical Trial Phase
Completed NCT04219189 - The Acute Effect of Vaping on Food Intake N/A
Completed NCT04054765 - A Virtual Reality Videogame for E-cigarette Prevention in Teens N/A
Terminated NCT04083469 - Identifying Student Opinion Leaders to Lead E-cigarette Interventions N/A
Completed NCT05473585 - Impact of New Standards for Tobacco Products Among Dual E-Cigarette/Combusted Cigarette Users - Project 2 N/A
Recruiting NCT04662658 - Hyperpolarized Xenon-129 MR Imaging of the Lung Phase 1/Phase 2
Recruiting NCT05482581 - The Impact of Policies Regarding E-cigarette on Adolescents and Young Adults' Cognition and Behavior for E-cigarette
Completed NCT05477888 - Psychometric Properties of the Chinese Version of Penn State [Electronic] Cigarette Dependence Index
Active, not recruiting NCT05120466 - Media Literacy for High School Tobacco Prevention N/A
Completed NCT05081843 - Pittsburgh and Rural Area High School Tobacco Prevention N/A
Active, not recruiting NCT04946825 - Quit Smoking Study for People Who Use E-Cigarettes Phase 2
Recruiting NCT04974580 - Research and Innovation to Stop E-cigarette/Vaping in Young Adults Phase 4
Not yet recruiting NCT06264154 - The Role of Flavor in the Substitutability of E-cigarettes for Combustible Cigarettes Among Persistent Smokers N/A
Completed NCT05431387 - A Study of Cytisinicline for Vaping Cessation in Adult Smokers Phase 2
Not yet recruiting NCT05932693 - Effect of Different E-cigarette Cooling Flavors on Adults' Sensory Experience TCORS 3.0 N/A
Completed NCT04854616 - Cessation of Smoking Trial in the Emergency Department N/A
Recruiting NCT05199480 - Understanding the Impact of Cartridge-Based Electronic Cigarettes and Generated Aerosols on Cardiopulmonary Health Early Phase 1
Completed NCT04150510 - Assessment of Smoking, Vaping, and Alcohol Consumption Behavior
Recruiting NCT04188197 - Assisting Smokers to Switch to a JUUL E-Cigarette by Devaluing Combustible Cigarettes Phase 3
Recruiting NCT05869318 - Respiratory Effects of E-Cigarettes in Obese Youth N/A
Recruiting NCT05432830 - Sex Differences in E-cig Perception: Study 1 N/A